Literature DB >> 16157286

Clinical aspects of 2541 patients with second stage human African trypanosomiasis.

Johannes Blum1, Caecilia Schmid, Christian Burri.   

Abstract

The clinical symptoms and signs of patients with second stage HAT are described for a large cohort of patients treated in a prospective multicentre, multinational study. Special emphasis is given to the influence of disease stage (duration, number of WBC in CSF) and patient age to the clinical picture. Even though the frequencies of symptoms and signs are highly variable between centres, the clinical picture of the disease is similar for all countries. Headache (78.7%), sleeping disorder (74.4%) and lymphadenopathy (56.1%) are the most frequent symptoms and signs and they are similar for all stages of the disease. Lymphadenopathy tends to be highest in the advanced second stage (59.0%). The neurological and psychiatric symptoms increase significantly with the number of WBC in the CSF indicating the stage of progression of the disease. Pruritus is observed in all stages and increases with the number of WBC in CSF from 30 to 55%. In children younger than 7 years, lymphadenopathy is less frequently reported (11.8-37.3%) than in older children or adults (56.4-61.2%). Fever is most frequently reported in children between 2 and 14 years of age (26.1-28.7%) and malnutrition is significantly more frequently observed in children of all ages (43-56%) than in adults (23.5%).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157286     DOI: 10.1016/j.actatropica.2005.08.001

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  56 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 2.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

3.  In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.

Authors:  Tanja Wenzler; Sihyung Yang; Donald A Patrick; Olivier Braissant; Mohamed A Ismail; Richard R Tidwell; David W Boykin; Michael Zhuo Wang; Reto Brun
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 4.  Human African trypanosomiasis in endemic populations and travellers.

Authors:  J A Blum; A L Neumayr; C F Hatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-07       Impact factor: 3.267

5.  Human African Trypanosomiasis Encephalitis in the United States: Serial Magnetic Resonance Imaging.

Authors:  Mary Carter Denny; Leon L Lai; Robert Laureno
Journal:  Neurohospitalist       Date:  2016-03-24

6.  Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling.

Authors:  Tom Bosschaerts; Martin Guilliams; Benoît Stijlemans; Yannick Morias; Daniel Engel; Frank Tacke; Michel Hérin; Patrick De Baetselier; Alain Beschin
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

7.  Sleeping Sickness Disrupts the Sleep-Regulating Adenosine System.

Authors:  Filipa Rijo-Ferreira; Theresa E Bjorness; Kimberly H Cox; Alex Sonneborn; Robert W Greene; Joseph S Takahashi
Journal:  J Neurosci       Date:  2020-10-23       Impact factor: 6.167

Review 8.  Pain management in neurocritical care.

Authors:  Axel Petzold; Armand Girbes
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

Review 9.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

Review 10.  The natural progression of Gambiense sleeping sickness: what is the evidence?

Authors:  Francesco Checchi; João A N Filipe; Michael P Barrett; Daniel Chandramohan
Journal:  PLoS Negl Trop Dis       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.